skip-to-main

Spikevax bivalent Original / Omicron 0.1 mg/mL dispersion for injection

Spikevax bivalent Original / Omicron is indicated for active immunisation to prevent COVID 19 disease caused by SARS- CoV-2 in individuals 18 years of age and older.

Patient Information Leaflet

Patient Information Leaflet

Summary of Product Characteristics

Summary of Product Characteristics

Spikevax (previously COVID-19 Vaccine Moderna)

Spikevax 0,20 mg/ml formulation

Interim authorisation is granted for the Spikevax emergency therapeutic product by the Health Sciences Authority (HSA) of Singapore for active immunisation to prevent COVID-19 disease caused by SARS- CoV-2 in individuals 6 years of age and older.

Patient Information Leaflet

Patient Information Leaflet

Summary of Product Characteristics

Summary of Product Characteristics

Spikevax (previously COVID-19 Vaccine Moderna)

Spikevax 0,10 mg/ml formulation

Interim authorisation is granted for the Spikevax emergency therapeutic product by the Health Sciences Authority (HSA) of Singapore for active immunisation to prevent COVID-19 disease caused by SARS- CoV-2 in individuals 6 months of age and older.

Patient Information Leaflet

Patient Information Leaflet

Summary of Product Characteristics

Summary of Product Characteristics

Tools

Temperature Excursion Tool

Temperature Excursion Tool

See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.

Contact Moderna